Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 12Completed 5Unknown 3Recruiting 3Terminated 2Not yet recruiting 2Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Breast 3

Conditions

Prostatic Neoplasms 9Breast Neoplasms 3Cardiovascular Diseases 2Salivary Gland Adenoma, Pleomorphic 1Prostate Cancer With ≤10 Bone Metastases 1Polycystic Ovary Syndrome 1Obesity 1Non-alcoholic Fatty Liver Disease 1Metabolic Syndrome 1Metabolic Diseases 1Infertility 1Hormone-receptor-positive Breast Cancer 1Eunuchism 1Diabetes Mellitus 1Advanced Breast Cancer 1

Interventions

Cyclophosphamide 77Docetaxel 69Capecitabine 64Trastuzumab 61Paclitaxel 50Tamoxifen 47Epirubicin 47Letrozole 44pyrotinib 40Fulvestrant 37Doxorubicin 35Vinorelbine 33Radiotherapy 32Carboplatin 32Anastrozole 28exemestane 27Neoadjuvant Therapy 24Drug Therapy 22Fluorouracil 21palbociclib 20Exercise 20Chemotherapy, Adjuvant 19Bevacizumab 18pertuzumab 16Goserelin 16Cisplatin 16liposomal doxorubicin 15Mammography 14Gemcitabine 14Blood Specimen Collection 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Breast Neoplasms × Gonadotropin-Releasing Hormone × Clear all
NCT06346457 2024-04-04

Breast Cancer & Antiestrogenic Therapy & Brain

International Research Training Group 2804

Unknown
180 enrolled
Breast

Breast Neoplasms

NCT02592746 2019-04-08

A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

Samsung Medical Center

Phase 2 Unknown
182 enrolled
Breast

Breast Neoplasms

NCT03543059 2018-06-01

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Sun Yat-sen University

Unknown
2,000 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡